Managers
Golub Capital, as Administrative Agent, Sole Lead Arranger and Sole Bookrunner, provided a GOLD financing and equity co-investment to support the acquisition of Active Day Senior Care by Audax Private Equity.
GOLD financings are Golub Capital One-Loan Debt facilities.
Active Day is a leading operator of adult day health services in the United States with 80 locations across the country. Each of its adult day health centres enables frail, elderly and disabled adults to live at home and remain independent in their communities, while receiving health care and supervision during the day, as well as providing relief and respite
Private equity firm Audax Group has partnered with management to acquire Active Day / Senior Care, a national adult care day provider, from Clearview Capital. Terms of the transaction have not been disclosed.
Headquartered in Trevose, Pennsylvania, Active Day / Senior Care is a leading national provider of adult day health services and in-home personal care. With more than 80 locations across the country, the Company provides therapeutic activities, opportunities for socialisation, and expert health and nursing care to improve its members’ daily functioning and delay the onset of chronic illness. The Company’s in-home senior care provides assistance with daily
Parthenon Capital Partners has completed its previously announced acquisition of Millennium Trust Company, a provider of technology-enabled asset custody solutions for institutions, advisors, and individuals.
Headquartered in Oak Brook, IL, Millennium Trust was established in 2000 to meet the market’s growing need for a more flexible provider of administrative and custodial services for both retirement and taxable investment accounts. Servicing the needs of individuals, institutions and advisors, the Company has continued to experience significant growth over the past few years across its three product areas: Rollover Solutions, Alternative Asset Custody Solutions, and Private Fund Custody.
The targets nascent sectors
Options available to fund managers marketing into Europe under the Alternative Investment Fund Managers Directive (AIFMD) will be the focus of a Guernsey funds masterclass in London next year.
The event, which takes place at the British Museum on Wednesday 3 February, will feature a panel debate among leading figures from the funds industry and a keynote speech from Lord Flight. The panel discussion will examine the benefits and suitability of National Private Placement (NPP) regimes and third country passporting under AIFMD.
In July the European Securities and Markets Authority (ESMA) made its recommendation to grant Guernsey a third country
Luxembourg is prepared and has a key role to play in ensuring the success of the new European Long-Term Investment Funds (ELTIFs), which came into being this week, according to the Association of the Luxembourg Fund Industry (ALFI).
ELTFIs have been established by the European Commission in a bid to give new impetus to the continent’s economic recovery.
“The objective of the EU in setting up ELTIFs was to boost smart, sustainable and inclusive growth,” says Denise Voss (pictured), Chairman of ALFI. “Take-up of the new funds may be a gradual process, but we believe that Luxembourg has the in-depth
GoEuro.co.uk, a platform for planning and booking all rail, bus and air transportation, has announced the closure of a Series B funding round totalling USD45 million.
The funding was led by Goldman Sachs and joined by new investors including Atomico, Yuri Milner and Tom Stafford, Sebastian Siemiatkowski (Klarna) and Ilkka Paananen (Supercell).
Naren Shaam, Founder and CEO of GoEuro, says: “This new investment is a huge endorsement to the progress we have made since our launch two and a half years ago. It will allow us to further accelerate our growth, and continue to build the most comprehensive platform for
Investindustrial is to acquires 100 per cent of the capital of luxury shoemaker Sergio Rossi from Kering. The deal includes all the industrial assets of Sergio Rossi, the rights attached to the brand and the entire distribution network.
The agreement will allow the Sergio Rossi brand to continue its path of development with a strategic partner that can support the brand solidly and with prospects for long-term growth.
Sergio Rossi is one of the most famous Italian luxury footwear brands, long known for its high quality production of shoes. The company has built its credibility on its unique craftsmanship and
Omnes Capital has invested EUR11.5 million in Dispam, a France-based specialist in temperature-controlled transportation, as part of a primary owner buy out (OBO) alongside current Chairman Pascal Masse.
Dispam was founded in 1971 and is based in Le Pontet in the Vaucluse region of France, offering its clients a range of high value-added solutions structured around two main areas of expertise: temperature-controlled (positive cold) transportation of fresh produce and general cargo; and complementary logistics services (management of logistics flows within the framework of integrated solutions – storage, warehousing, consolidation/deconsolidation, order preparation).
The group’s main clients are food manufacturers (60
Gryphon Investors (“Gryphon”), a middle-market private equity firm based in San Francisco, has completed a majority investment in Jensen Hughes, a specialist in fire protection engineering, fire code consulting and related life safety services in commercial, institutional, and industrial facilities.
CEO Phil Rogers and the remainder of the Company’s management team have retained a significant ownership position in the company and will continue to lead Jensen Hughes after the closing of the transaction. Terms of the deal were not disclosed.
“Gryphon has a long and successful history of investing in engineering and other professional services companies and we look forward
Sofinnova Partners, a European venture capital firm specialised in Life Sciences, has closed Sofinnova Capital VIII at EUR300 million, above the initial fund target of EUR250 million.
Following the raise of its previous fund at EUR240m in 2012, this new fund brings the total amount under management at Sofinnova Partners to EUR1.5 billion (USD1.6 billion).
Pursuing the strategy it has consistently applied over the years, Sofinnova Capital VIII will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors. Sofinnova Partners will seek to invest as a founding and lead investor in start-ups and corporate
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
